These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 15172084

  • 1. Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women.
    Lambrinoudaki IV, Christodoulakos GE, Panoulis CP, Rizos DA, Dendrinos SG, Liakakos T, Augoulea AD, Creatsas GC.
    Maturitas; 2004 Jun 15; 48(2):107-13. PubMed ID: 15172084
    [Abstract] [Full Text] [Related]

  • 2. Conjugated estrogen/progestagen versus tibolone hormone replacement therapy in postmenopausal women: Effects on carbohydrate metabolism and serum sex hormone-binding globulin.
    Odmark IS, Carlström K, Jonsson B, Jonasson AF.
    Maturitas; 2006 Jan 10; 53(1):89-96. PubMed ID: 15964160
    [Abstract] [Full Text] [Related]

  • 3. Cognitive function variations in postmenopausal women treated with continuous, combined HRT or tibolone. A comparison.
    Pan HA, Wang ST, Pai MC, Chen CH, Wu MH, Huang KE.
    J Reprod Med; 2003 May 10; 48(5):375-80. PubMed ID: 12815913
    [Abstract] [Full Text] [Related]

  • 4. Circulating leptin and ghrelin are differentially influenced by estrogen/progestin therapy and raloxifene.
    Lambrinoudaki IV, Christodoulakos GE, Economou EV, Vlachou SA, Panoulis CP, Alexandrou AP, Kouskouni EE, Creatsas GC.
    Maturitas; 2008 Jan 20; 59(1):62-71. PubMed ID: 18164562
    [Abstract] [Full Text] [Related]

  • 5. A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability.
    Baracat EC, Barbosa IC, Giordano MG, Haidar MA, Marinho RM, Menegocci JC, Morais KM, Tomaz G, Wehba S.
    Climacteric; 2002 Mar 20; 5(1):60-9. PubMed ID: 11974560
    [Abstract] [Full Text] [Related]

  • 6. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
    Keramaris NC, Christodoulakos GE, Lambrinoudaki IV, Dalamanga A, Alexandrou AP, Bramis J, Bastounis E, Creatsas GC.
    Climacteric; 2007 Oct 20; 10(5):400-7. PubMed ID: 17852143
    [Abstract] [Full Text] [Related]

  • 7. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
    Christodoulakos G, Lambrinoudaki I, Panoulis C, Sioulas V, Rizos D, Caramalis G, Botsis D, Creatsas G.
    Maturitas; 2005 Apr 11; 50(4):321-30. PubMed ID: 15780533
    [Abstract] [Full Text] [Related]

  • 8. A comparative study of the effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on blood coagulability.
    Skouby SO, Sidelmann JJ, Nilas L, Jespersen J.
    Hum Reprod; 2007 Apr 11; 22(4):1186-91. PubMed ID: 17204528
    [Abstract] [Full Text] [Related]

  • 9. Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene.
    Tommaselli GA, Di Carlo C, Di Spiezio Sardo A, Bifulco G, Cirillo D, Guida M, Capasso R, Nappi C.
    Menopause; 2006 Apr 11; 13(4):660-8. PubMed ID: 16837888
    [Abstract] [Full Text] [Related]

  • 10. Flow resistance in carotid and middle cerebral arteries in postmenopausal women: a comparative study of tibolone and continuous combined hormone replacement therapy.
    Pan HA, Wang ST, Chen CH, Pai MC, Wu MH, Huang KE.
    Climacteric; 2002 Sep 11; 5(3):259-65. PubMed ID: 12419084
    [Abstract] [Full Text] [Related]

  • 11. Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels.
    Gol M, Akan P, Dogan E, Karas C, Saygili U, Posaci C.
    Maturitas; 2006 Feb 20; 53(3):252-9. PubMed ID: 15990257
    [Abstract] [Full Text] [Related]

  • 12. Short-term effects of hormone therapy on serum C-reactive protein levels in postmenopausal women.
    Kiran H, Kiran G.
    Arch Gynecol Obstet; 2006 Apr 20; 274(1):9-12. PubMed ID: 16369811
    [Abstract] [Full Text] [Related]

  • 13. The effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on cardiovascular metabolic risk factors.
    Skouby SO, Sidelmann JJ, Nilas L, Gram J, Jespersen J.
    Climacteric; 2008 Apr 20; 11(6):489-97. PubMed ID: 18991076
    [Abstract] [Full Text] [Related]

  • 14. Comparative effects of continuous combined hormone therapy and tibolone on body composition in postmenopausal women.
    Ziaei S, Moaya M, Faghihzadeh S.
    Climacteric; 2010 Jun 20; 13(3):249-53. PubMed ID: 19848555
    [Abstract] [Full Text] [Related]

  • 15. Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.
    Ziaei S, Moghasemi M, Faghihzadeh S.
    Climacteric; 2010 Apr 20; 13(2):147-56. PubMed ID: 19731119
    [Abstract] [Full Text] [Related]

  • 16. Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women.
    Osmanağaoğlu MA, Osmanağaoğlu S, Osmanağaoğlu T, Okumuş B, Bozkaya H.
    Fertil Steril; 2005 Aug 20; 84(2):384-93. PubMed ID: 16084879
    [Abstract] [Full Text] [Related]

  • 17. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
    Yasui T, Uemura H, Umino Y, Takikawa M, Saito S, Kuwahara A, Matsuzaki T, Maegawa M, Furumoto H, Miura M, Irahara M.
    Maturitas; 2005 Jan 10; 50(1):19-29. PubMed ID: 15590210
    [Abstract] [Full Text] [Related]

  • 18. Effects of hormone therapy and tibolone on body composition and serum leptin levels in postmenopausal women.
    Dedeoğlu EN, Erenus M, Yörük P.
    Fertil Steril; 2009 Feb 10; 91(2):425-31. PubMed ID: 18249383
    [Abstract] [Full Text] [Related]

  • 19. Circulating levels of atherogenesis-associated adipocytokines and apoptotic markers are differentially influenced by hormone therapy, tibolone and raloxifene in healthy postmenopausal women.
    Christodoulakos GE, Lambrinoudaki IV, Creatsa MG, Economou EV, Siasou Z, Panoulis CP, Kalligerou I, Papadias C.
    Climacteric; 2008 Apr 10; 11(2):155-65. PubMed ID: 18365858
    [Abstract] [Full Text] [Related]

  • 20. Effect on sexual life--a comparison between tibolone and continuous combined conjugated equine estrogens and medroxyprogesterone acetate.
    Uygur D, Yeşildaglar N, Erkaya S.
    Gynecol Endocrinol; 2005 Apr 10; 20(4):209-12. PubMed ID: 16019363
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.